Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.33 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.32 |
| ▸ | PTGES | O14684 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12020667 | 0.78 | MAPT (0.41) | CSNK2A1HCAR1PTGESKDM4EPOLB | |
| SCHEMBL20495165 | 0.76 | TRPV1 (0.36) | PTGESKDM4EMAPTKMT2A | |
| SCHEMBL2317964 | 0.73 | EPRS1 (0.40) | HCAR1 | |
| SCHEMBL1701401 | 0.69 | NPSR1 (0.40) | CSNK2A1KDM4EPOLBMAPTHPGD | |
| SCHEMBL12501397 | 0.69 | MAPT (0.49) | CSNK2A1KDM4EPOLBMAPTHPGD | |
| SCHEMBL2319088 | 0.69 | NOTUM (0.46) | KDM4EMAPTMEN1KMT2A | |
| SCHEMBL10722861 | 0.68 | NPSR1 (0.50) | CSNK2A1KDM4EPOLBMAPTHPGD | |
| SCHEMBL19742259 | 0.67 | CACNA1H (0.46) | POLB | |
| SCHEMBL20495249 | 0.67 | S1PR1 (0.39) | KDM4E | |
| SCHEMBL1509452 | 0.67 | NOS1 (0.38) | CSNK2A1PTGESKDM4EPOLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011097491-A1 | BENZIMIDAZOLE ANTIVIRAL AGENTS | GLAXOSMITHKLINE LLC (US) | 2011-08-11 | — | — | WO | disclosed |